LFWDNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Lifeward Ltd.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$5.93−0.07 (-1.17%)

Close on Oct 19, 2026

Market cap: $16.58M
P/E (TTM): –
Dividend yield: –

Fundamental chart

Pick a measure to chart its full history

$22.03MFY2025, +27.1% a year since FY2012

Where these numbers come from

Parsed from the XBRL in Lifeward's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Mar 18, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LFWD.

Revenue growth-10.7% · median 5.9%

Gross margin36.0% · median 68.7%

Operating margin-104.2% · median -35.3%

Net margin-141.3% · median -38.8%

Company	Revenue	Growth
APT	$61.91M	+5.7%
MYO	$43.26M	+6.1%
LFWD	$21.82M	-10.7%
LGMK	$12.54M	+20.6%
MLSS	$9.42M	+3.7%
ZJYL	–	–

Company

Next earnings (est.): Nov 13, 2026, before open
Exchange: Nasdaq
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Fiscal year ends: December 31
Employees: 81
Auditor: KOST FORER GABBAY & KASIERER
SEC CIK: 1607962

Advertisement
300 × 250